Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Shaopu Zhu, Kang Yang, Shiyi Yang, Li Zhang, Maoming Xiong, Jiawei Zhang & Bo Chen. (2022) A high bile acid environment promotes apoptosis and inhibits migration in pancreatic cancer. Bioengineered 13:3, pages 6719-6728.
Read now
Read now
Stefano Gitto, Valeria Guarneri, Alessandro Sartini & Pietro Andreone. (2018) The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives. Expert Review of Gastroenterology & Hepatology 12:2, pages 165-171.
Read now
Read now
Christopher L Bowlus. (2016) Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection. Hepatic Medicine: Evidence and Research 8, pages 89-95.
Read now
Read now
Kidist K Yimam & Christopher L Bowlus. (2014) Obeticholic acid for the treatment of primary biliary cirrhosis. Expert Opinion on Orphan Drugs 2:12, pages 1351-1358.
Read now
Read now
Articles from other publishers (21)
Fay Louise Murray-Brown. (2021) Naltrexone for cholestatic itch: a systematic review. BMJ Supportive & Palliative Care 11:2, pages 217-225.
Crossref
Crossref
Tadashi Namisaki, Yukihisa Fujinaga, Kei Moriya & Hitoshi Yoshiji. (2021) The association of histological progression with biochemical response to ursodeoxycholic acid in primary biliary cholangitis. Hepatology Research 51:1, pages 31-38.
Crossref
Crossref
Wen Xu, Yan-nan Xu, Xu Zhang, Ying Xu, Xun Jian, Jia-mei Chen, Gao-feng Chen, Hua Zhang, Ping Liu & Yong-ping Mu. (2020) Hepatic stem cell Numb gene is a potential target of Huang Qi Decoction against cholestatic liver fibrosis. Scientific Reports 10:1.
Crossref
Crossref
Liteng Lin, Hengye Gong, Rui Li, Jingjun Huang, Mingyue Cai, Tian Lan, Wensou Huang, Yongjian Guo, Zhimei Zhou, Yongcheng An, Zhiwei Chen, Licong Liang, Yong Wang, Xintao Shuai & Kangshun Zhu. (2020) Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation. Advanced Science 7:7, pages 1903138.
Crossref
Crossref
Zobair M. Younossi, Pegah Golabi & Linda Henry. (2019) A Comprehensive Review of Patient-reported Outcomes in Patients With Chronic Liver Diseases. Journal of Clinical Gastroenterology 53:5, pages 331-341.
Crossref
Crossref
Omer Shahab, Mehmet Sayiner, James Paik, Sean Felix, Pegah Golabi & Zobair M. Younossi. (2019) Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States. Hepatology Communications 3:3, pages 356-364.
Crossref
Crossref
Mehmet Sayiner, Pegah Golabi, Maria Stepanova, Issah Younossi, Fatema Nader, Andrei Racila & Zobair M. Younossi. (2019) Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Use. Hepatology 69:1, pages 237-244.
Crossref
Crossref
Xiao-Long He, Li-Ting Wang, Xiang-Zhong Gu, Jie-Xin Xiao & Wen-Wei Qiu. (2018) A facile synthesis of ursodeoxycholic acid and obeticholic acid from cholic acid. Steroids 140, pages 173-178.
Crossref
Crossref
Tanja M. Šarenac & Momir Mikov. (2018) Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients. Frontiers in Pharmacology 9.
Crossref
Crossref
Roberto Pellicciari, Mark Pruzanski & Antimo Gioiello. 2018. Successful Drug Discovery. Successful Drug Discovery
197
244
.
Susanna Tan, Napatkamon Ayutyanont, Bikash Bhattarai, Zohreh Movahedi, Lakshmi Jayaram, Robert Gish & Abdul Nadir. (2017) Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona. BMJ Open Gastroenterology 4:1, pages e000158.
Crossref
Crossref
Tadashi Namisaki, Kei Moriya, Ryuichi Noguchi, Mitsuteru Kitade, Hideto Kawaratani, Junichi Yamao, Akira Mitoro, Motoyuki Yoshida, Masayoshi Sawai, Masakazu Uejima, Tsuyoshi Mashitani, Kosuke Takeda, Yasushi Okura, Kosuke Kaji, Hiroaki Takaya, Yosuke Aihara, Akitoshi Douhara, Norihisa Nishimura, Yasuhiko Sawada, Shinya Sato, Kenichiro Seki & Hitoshi Yoshiji. (2017) Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis. Hepatology Research 47:3, pages E178-E186.
Crossref
Crossref
Jairo Morantes-Caballero, Nairo Cano-Arenas & Juan Francisco Rodríguez de Narváez. (2017) Reynolds Syndrome: a rare rheumatologic disease that internists should have in mind. Case report. Case reports 3:1.
Crossref
Crossref
Xiao Zhang, Ying Xu, Jia-Mei Chen, Cheng Liu, Guang-Li Du, Hua Zhang, Gao-Feng Chen, Shi-Li Jiang, Cheng-Hai Liu, Yong-Ping Mu & Ping Liu. (2017) Huang Qi Decoction Prevents BDL-Induced Liver Fibrosis Through Inhibition of Notch Signaling Activation. The American Journal of Chinese Medicine 45:01, pages 85-104.
Crossref
Crossref
Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Takeda, Yasushi Okura, Hiroaki Takaya, Norihisa Nishimura, Kenichiro Seki, Kosuke Kaji, Shinya Sato, Yasuhiko Sawada, Junichi Yamao, Akira Mitoro, Masakazu Uejima, Tsuyoshi Mashitani, Naotaka Shimozato, Keisuke Nakanishi, Masanori Furukawa, Soichiro Saikawa, Takuya Kubo & Hitoshi Yoshiji. (2017) Clinical significance of the Scheuer histological staging system for primary biliary cholangitis in Japanese patients. European Journal of Gastroenterology & Hepatology 29:1, pages 23-30.
Crossref
Crossref
Xiao Zhang, Guangli Du, Ying Xu, Xuewei Li, Weiwei Fan, Jiamei Chen, Cheng Liu, Gaofeng Chen, Chenghai Liu, Mark A Zern, Yongping Mu & Ping Liu. (2016) Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes. Laboratory Investigation 96:3, pages 350-360.
Crossref
Crossref
Dario Degiorgio, Andrea Crosignani, Carla Colombo, Domenico Bordo, Massimo Zuin, Emanuela Vassallo, Marie-Louise Syrén, Domenico A. Coviello & Pier Maria Battezzati. (2015) ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression. Journal of Gastroenterology 51:3, pages 271-280.
Crossref
Crossref
Valentina Sepe, Eleonora Distrutti, Vittorio Limongelli, Stefano Fiorucci & Angela Zampella. (2015) Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical application. Future Medicinal Chemistry 7:9, pages 1109-1135.
Crossref
Crossref
Mu Yongping, Xiao Zhang, Li Xuewei, Weiwei Fan, Jiamei Chen, Hua Zhang, Gaofeng Chen, Chenghai Liu & Ping Liu. (2015) Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation. Journal of Ethnopharmacology 169, pages 200-209.
Crossref
Crossref
William Otero R. (2015) El hígado en reumatología. Revista Colombiana de Reumatología 22:1, pages 1-3.
Crossref
Crossref
Toru Shizuma. (2015) Clinical Characteristics of Concomitant Systemic Lupus Erythematosus and Primary Biliary Cirrhosis: A Literature Review. Journal of Immunology Research 2015, pages 1-9.
Crossref
Crossref